Drugs Patient Level Contract Monitoring
Information Standard Notice
Acting under delegated authority from the Secretary of State for Health, the Data Coordination Board has approved a change to an existing information standard for publication under section 250 of the Health and Social Care Act 2012.
Important: Full conformance date
You must comply with this change by the full conformance date: 1 October 2021
Standard definition
- Unique identifier
DCB2212 Amd 74/2020
- Name
- Drugs Patient Level Contract Monitoring
- Approval date
- 25 March 2021
- Publication date
- 8 April 2021
- Documentation
- opens in a new tab
(opens in new tab)
Standard definition
- Description
- This is one of a set of standards introduced by NHS England, initially on a voluntary basis, to enable national consistency of the flow of cost and activity information from providers to commissioners.
About this change
- Scope
- NHS Services
- Applies to
- All commissioners of NHS-funded services
- All NHS/independent providers, operating under the NHS Standard Contract
- NHS ambulance service providers, operating under the NHS Standard Contract
- Impacts upon
- Implementation of this information standard impacts all health IT systems suppliers providing systems to the above providers; suppliers should work with their customers to determine necessary changes.
- Link to further information
- Further information
Contacts
- Sponsor
Ming Tang, Managing Director of Data and Analytics, NHS England
- SRO
- Vicky Mathwin, Deputy Director of Information and Intelligence, Specialised Services National Support Team, NHS England
- Business Lead
- Martin Hart, Assistant Head of Information (Reporting), NHS England
- Help Desk
Dates
- Implementation Date
- 1 September 2021
- Full Conformance Date
- 1 October 2021
- Post Implementation Review date
- 30 September 2022